Charles River Labs (CRL) PT Lowered to $275 at Baird
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $339.66 -1.51%
Rating Summary:
24 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 11 | New: 48
Rating Summary:
24 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 11 | New: 48
Join SI Premium – FREE
Baird analyst Eric W. Coldwell lowered the price target on Charles River Labs (NYSE: CRL) to $275.00 (from $277.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Charles River, Labcorp, and FDA sign drug abuse potential research pact
- Spotify (SPOT) PT Raised to $625 at Raymond James
- Danaher (DHR) PT Raised to $260 at Stifel as Nonrespiratory Core Growth Exceeded Expectations
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
